All Products
  • Antibodies
  • Kits
  • Peptides
  • Proteins
  • Biochemicals
CH
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
Biosimilar Antibodies
Path：Home > Products > Antibodies > Biosimilar Antibodies
Products
Products
Research Grade Olendalizumab
All
  • Catalog： TD-HF687036
  • Clonality： mAb
  • Application： Research Grade Biosimilar
  • Synonyms： ALXN1007,CAS:1337966-73-0
  • Specification：
    1mg
  • Prices：
    ¥询价
Customized service consulting
Information
FAQ
Experimental program
Related Products
Bibliography

Research Grade Olendalizumab

Catalog No. TD-HF687036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG2-G4-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target CPAMD4, C5, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, Complement C5
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P01031
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ALXN1007,CAS:1337966-73-0
Background Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus.
Note For research use only. Not for use in clinical or therapeutic applications.